3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
7
Hereditary Sensory and Autonomic Neuropathies
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Rectal Neoplasms
1
Neoplasms
1
Hyperglycemia
1
Exanthema
1
Advanced or Metastatic ER+ Breast Cancer
1
Advanced Breast Cancer
1
Interventions
Letrozole
2
Goserelin
2
Fulvestrant
2
olaparib
1
abemaciclib
1
Trastuzumab
1
Lead
1
Aromatase Inhibitors
1
Anastrozole
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Advanced Breast Cancer
×
Alpelisib
×
Clear all
NCT04862143
2024-06-20
TELEPIK
Novartis
Phase 2
Terminated
2 enrolled
10 charts